Quoin Pharmaceuticals (QNRX) Long-Term Investments (2022 - 2025)

Quoin Pharmaceuticals has reported Long-Term Investments for 4 years, with the latest figure at $3.6 million in Q3 2025.

• Quarterly Long-Term Investments fell 50.0% year-over-year to $3.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3.6 million (down 50.0% YoY) and the FY2024 annual result came in at $10.4 million, up 25.8% from the prior year.
• Long-Term Investments declined to $3.6 million in Q3 2025 per QNRX's latest filing, from $6.1 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $13.6 million in Q1 2023 and troughed at $3.6 million in Q3 2025.
• A 4-year average of $9.3 million and a median of $9.9 million in 2022 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments advanced 25.8% in 2024, then plunged 50.0% in 2025.
• Over 4 years, Long-Term Investments stood at $10.0 million in 2022, then dropped by 17.0% to $8.3 million in 2023, then rose by 25.8% to $10.4 million in 2024, then tumbled by 65.5% to $3.6 million in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $3.6 million, $6.1 million, and $7.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.